Skip to main content
Go to the home page of the European Commission (opens in new window)
English en
CORDIS - EU research results
CORDIS

Beyond a snapshot: Spatiotemporal Multiomics for the study of Breast Cancer phenotypic transitions

Project description

Understanding phenotyping transitions in breast cancer research

Phenotypic transitions, including differentiation and metabolic reprogramming, are difficult to study due to the transient nature of specific cell types and the limitations of high-dimensional phenotyping methods. The ERC-funded ESPRESSO-Omics project will explore phenotypic transitions in chemotherapy resistance. It aims to create a framework combining spatial proteomics with the novel omics approach ESPRESSO, allowing real-time monitoring of organelle and protein expression in living cells. This will help identify subpopulations that may develop chemoresistance and the transitions that lead to it, offering new insights for therapeutic targets. Deliverables will include an ESPRESSO-Omics atlas, a high-throughput hyperspectral light-sheet microscope, and a machine learning framework, all focused on breast cancer research.

Objective

This proposal aims to address a critical knowledge gap in understanding phenotypic transitions in the context of chemotherapy resistance. Phenotypic transitions encompass various mechanisms that modify cellular phenotypes over time, including differentiation and metabolic reprogramming, among others. As some cellular phenotypes are transient and chemoresistant cells constitute a rare subpopulation, studying these important phenomena is challenging even with modern, high dimensional phenotyping methods (e.g. proteomics and transcriptomics), as they are intrinsically destructive for the sample and can only provide a single snapshot of these fleeting cellular states.

To overcome this limitation, I propose the development of a groundbreaking framework that combines spatial proteomics with ESPRESSO, a novel omics approach I developed for high-dimensional phenotyping applicable to living system. The resulting ESPRESSO-Omics framework will enable real-time monitoring of both organelle and protein expression profiles in living cells, that will allow us to go back in time and identify the subpopulation with the potential to become chemoresistant, as well as the transitions that lead it there, providing a revolutionary point of view in the identification of therapeutic targets.
Multiple deliverables including an ESPRESSO-Omics atlas, a high-throughput hyperspectral light-sheet microscope and a machine learning framework will be provided during the course of this award, articulated over two work packages (WPs):

WP1: Establishment of the ESPRESSO-omics framework
WP2: Investigation of phenotypic transitions in breast cancer

Understanding phenotypic transitions has broad implications, not only in breast cancer research but also in other cancers and biological systems. The open-source cell atlas, instrumentation specifications and data analysis tools will be valuable resources for the scientific community, democratizing advanced tools for the study of phenotypic transitions

Fields of science (EuroSciVoc)

Keywords

Programme(s)

Topic(s)

Funding Scheme

HORIZON-ERC - HORIZON ERC Grants

See all projects funded under this funding scheme

Call for proposal

(opens in new window) ERC-2025-STG

See all projects funded under this call

Host institution

INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE
Net EU contribution
€ 1 498 973,00
Address
RUE DE TOLBIAC 101
75654 Paris
France
Region
Ile-de-France Ile-de-France Paris
Activity type
Research Organisations
Links
Total cost
€ 1 498 973,00

Beneficiaries (1)